Genome-based therapeutics : targeted drug discovery and development : workshop summary

Genome-based therapeutics targeted drug discovery and development : workshop summary

"The number of new drug approvals has remained reasonably steady for the past 50 years at around 20 to 30 per year, while at the same time the total spending on health-related research and development has tripled since 1990. There are many suspected causes for this trend, including increases in...

Full description

Bibliographic Details
Corporate Authors: Institute of Medicine (U.S.). Roundtable on Translating Genomic-Based Research for Health, issuing body (issuing body), Institute of Medicine (U.S.). Board on Health Sciences Policy, issuing body
Other Authors: Berger, Adam C., contributor (contributor), Olson, Steve, 1956- contributor
Format: eBook
Language:Inglés
Published: Washington, District of Columbia : National Academies Press [2012]
Edition:1st ed
Subjects:
Drugs > United States > Design > Congresses.
Pharmaceutical technology > United States > Congresses.
Pharmaceutical industry > United States > Congresses.
Genomics > United States > Congresses.
See on Biblioteca Universitat Ramon Llull:https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009622301906719
Table of Contents:
  • Introduction
  • The current landscape
  • Case studies: The development of Crizotinib for treatment of non-small-cell lung cancer; Use of genetics to inform drug development for the treatment of schizophrenia; A genetic approach to the treatment of cystic fibrosis
  • Emerging technologies in drug development: Large-scale whole-genome sequencing; The value of clinical next-generation sequencing to drug developers; The uses of genomic information
  • Evolving paradigms: Foundations and drug development: an example; Genomics and regulatory science; Pharmacy benefit management and pharmacogenomics; Repurposing of drugs
  • Forging collaborative strategies for the development of personalized medicine: The need for collaboration; FDA initiatives; NCATS initiatives; Biospecimens and databases; Reducing health disparities; Patient and physican education; An emphasis on the science.

Similar Items